MAP2K7 and infection: The MEK inhibitor trametibinib displayed strong inhibitory activity against MERS-CoV infection in Huh7 human hepatocytes when administered prior to and post-infection, suggesting that ERK/MAPK pathway signaling may be important for viral entry and viral replication stages of the MERS-CoV life cycle38.